Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs
28th July 2025 Uncategorised 0After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans to offer jobs to about half of the biotech’s employees. Once the deal closes, Adaptimmune will reduce its remaining workforce by 62%.
More: Adaptimmune sells 4 cell therapies to pharma for M, plans layoffs
Source: fierce
